Evidence map›Paper›PMID 24707147›Full record

ArticleWorld journal of gastroenterology2014

Tumors of the angle of Treitz: a single-center experience.

Yi-Bin Xie, Hao Liu, Liang Cui, Gu-Sheng Xing, Lin Yang, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yi-Bin XieYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Hao LiuYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Liang CuiYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Gu-Sheng XingYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Lin YangYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Yue-Min SunYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Xiao-Feng BaiYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Dong-Bing ZhaoYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Cheng-Feng WangYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Yan-Tao TianYi-Bin Xie, Hao Liu, Liang Cui, Yue-Min Sun, Xiao-Feng Bai, Dong-Bing Zhao, Cheng-Feng Wang, Yan-Tao Tian, Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Peking Union Medical College Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo explore the feasibility and oncologic outcomes of segmental jejunal resection on the left side of the mesenteric vessels in patients with tumors of the angle of Treitz using data from a single center.

methodsThirteen patients with tumors of the angle of Treitz who underwent surgery at our institution were prospectively followed. A segmental jejunal resection on the left side of the mesenteric vessels was performed in all patients. Formalin-fixed and paraffin-embedded tumor samples were examined. The primary end point of this analysis was disease-free survival.

resultsIn this study, there were 8 males and 5 females (mean age, 50.1 years; range, 36-74 years). The mean tumor size was 8.1 cm (range, 3.2-15 cm). Histologic examination showed 11 gastrointestinal stromal tumors (GISTs) and 2 adenocarcinomas. Five of the GIST patients presented with potential low risk, and 6 presented with intermediate and high risk, according to the National Institutes of Health criteria. One potentially high-risk patient showed tumor progression at 46 mo and died 52 mo after surgery. One patient with locally advanced adenocarcinoma received neoadjuvant chemotherapy and adjuvant radiotherapy, but the disease progressed, and the patient died 9 mo after surgery. One GIST patient without progression died 16 mo after surgery because of a postoperative intestinal obstruction. The median overall survival rate was 84.6 mo, and the median disease-free survival rate was 94.5 mo.

conclusionThe overall survival of patients with tumors of the angle of Treitz was encouraging even when the tumor size was relatively large. A segmental resection on the left side of the mesenteric vessels is considered to be a reliable and curative option for tumors of the angle of Treitz.

Indexed as

AdultAgedAnastomosis, SurgicalCell DifferentiationDisease-Free SurvivalDuodenumFemaleFormaldehydeGastrointestinal Stromal TumorsHumansImmunohistochemistryJejunumMaleMiddle AgedParaffinPrognosisFormaldehydeParaffinAdenocarcinomaAngle of TreitzGastrointestinal stromal tumorPrognosisSurgical treatment

Identifiers

PMID24707147
PMCPMC3974531
OpenAlexW2035749276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.